TOTECH CORPORATION
9960・Prime Market・Wholesale Trade
Governance
Company with an Audit and Supervisory Committee (transitioned in June 2023). The Board of Directors consists of 7 directors (4 of whom are outside directors), and an executive officer system has been introduced. A Nomination and Compensation Committee chaired by an independent outside director has been established. The Board of Directors meets 15 times per year, with all officers maintaining a high attendance rate.
Risk Management
The company has established a Risk Management Committee based on its Basic Risk Management Regulations, promoting the prevention and recurrence prevention of significant risks. Climate change risk is identified and assessed by the Sustainability Committee in collaboration with the Sustainability Promotion Group, with a system in place to report response status to the Board of Directors.
Shareholder Returns
Annual dividend for FY2026 (ending March 2026) is ¥128 per share (interim ¥35, year-end ¥93), with a payout ratio of 40.1%. During the Second Medium-Term Management Plan period, the dividend policy shifts to DOE 6% plus progressive dividend. The forecast for FY2027 (ending March 2027) is ¥128 (payout ratio of 38.3%). Share buybacks (¥779 million) were also conducted.
Dividend Policy
During the Second Medium-Term Management Plan period (from FY2026), the policy shifts from the conventional payout ratio standard to "DOE (dividend on equity ratio) 6% plus progressive dividend," enabling stable shareholder returns unaffected by fluctuations in single-year net income. Dividends are paid twice a year (interim and year-end) in principle. The actual result for FY2026 (ending March 2026) was an annual dividend of ¥128 (payout ratio of 40.1%, DOE of 7.8%), and the forecast for FY2027 (ending March 2027) is an annual dividend of ¥128 (payout ratio of 38.3%).
ESG
The company expressed support for the TCFD recommendations (May 2023) and conducted 1.5°C and 4°C scenario analyses. It has set targets to reduce Scope 1+2 GHG emissions by 38% by FY2030 and by 100% by FY2050, compared to FY2021 levels. On the human capital front, the company disclosed KPIs such as certification as an Excellent Health Management Corporation (for two consecutive years), an engagement score of 76.4pt, and a turnover rate of 4.3%, and has set targets for FY2030.
Last updated: June 23, 2026